Povidine Iodine Prep Pads Are Voluntarily Recalled
- By BSTQ Staff
On March 16, H&P Industries Inc., the parent company of the Triad Group of Hartland, Wis., voluntarily recalled all lots of povidine iodine prep pads. The recalled products all were distributed in the United States and include those pads made by H&P Industries and packaged under the names Cardinal Health, Medical Specialties,VHA, Triad, Triad Plus, North Safety and Total Resources. According to the recall notice, the pads may be contaminated with Elizabethkingia meningoseptica, an organism that has caused rare but serious infections in humans, including meningitis in newborn infants, pneumonia in patients on ventilators, and necrotizing fasciitis, more commonly known as flesh-eating bacteria disease. However, there have been no reported illnesses from the contaminated pads as of this writing.
This recall comes more than two months after H&P Industries issued a global recall of hundreds of millions of contaminated alcohol prep pads and wipes because of potential contamination with a rare bacteria called Bacillus cereus. This contamination was found after children in Colorado came down with bloodstream infections caused by the organism and a Colorado hospital cultured the pads and found the potentially life-threatening bacteria. A 2-year-old boy in Houston died from bacterial meningitis after becoming infected with the bacteria.
Specific customers distributing povidine iodine prep pads and selling them at the wholesale and hospital level are being notified by certified mail with instructions on how to return the product. Consumers who have any of these types of products in their possession should not use the product and should return it to the place it was purchased for a full refund. Or, they can call customer service at H&P Industries Inc. from Monday through Friday between the hours of 8:30 a.m. and 4 p.m. central time at(262) 538-2900 to be issued a return authorization number and return arrangements.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program at www.fda.gov/medwatch/report.htmor by calling (800) 323-0178.